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ABSTRACT
he clinical recognition of thyroid disease, 
especially in its most florid form is relatively 
easy. However, in some cases, the presence of T
thyroid disease is not immediately obvious and a 
diagnosis is made only when thyroid function tests 
(TFTs) are requested on the basis of nonspecific 
symptoms/signs such as lethargy, weight loss or 
palpitations. Fortunately, the interpretation of the 
results of most TFTs is straightforward especially when 
combined measurements (TSH with T4 or T3 or both) 
are ordered. Nevertheless, a small albeit important 
number of situations in which the results of TSH, T4 
and T3 seem to point in different directions remain, 
thereby producing clinical confusion. In most of these 
cases, careful clinical reassessment of thyroid status, 
together with consideration of possible confounding 
factors such as pregnancy, intercurrent (non-thyroidal) 
illness or drug therapy will readily identify the cause of 
1
such apparently anomalous/discordant TFTs.  On rare 
occasions, thyroid hormone assay interference or 
genetic/acquired disorders of the hypothalamic-
pituitary-thyroid (HPT) axis may need to be screened 
1
for to arrive at a diagnosis.  This review highlights the 
causes of the different patterns of abnormal thyroid 
function seen in clinical practice, including the so-
called 'funny' TFTs and the practical approach to their 
evaluation.
ASSESSING THYROID FUNCTION: WHICH TEST 
IS THE BEST? 
In any given individual, thyroid hormone (both 
thyroxine, T4 and triiodothyronine, T3) levels remain 
relatively constant, reflecting the set-point of the HPT 
2
axis in that individual.  Changes in thyroid status are 
almost always associated with concordant changes in 
thyroid hormones  and thyrotropin (TSH) 
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with low normal or partially suppressed TSH. Where 
total TH concentrations are measured, reductions in 
TT4 and in particular TT3 are common even in mild 
NTI, and are usually more marked than the 
corresponding decreases  in  free  hormone 
concentrations (likely reflecting reduced serum TH 
binding capacity in acute and chronically ill patients, 
secondary to a fall in TH binding protein 
3
concentrations and/or impaired T4/T3 binding).  The 
magnitude of T4 decrease has been reported to 
5
correlate with a less favourable outcome.
Effect of Medications
Medication history is an essential part of the evaluation 
of any patient with thyroid disease since commonly 
prescribed medications can affect thyroid function 
leading to anomalous and/or discordant TFTs. In 
patients taking levothyroxine, the finding of elevated 
TSH in conjunction with elevated free T4 and/or T3 
may indicate poor compliance, with the ingestion of a 
large dose of levothyroxine just prior to the test. This 
pattern of TFTs may also be caused by malabsorption of 
6
levothyroxine.  Poor absorption can be due to small 
bowel disease, or iatrogenically by cholestyramine or 
7
iron therapy.  Amiodarone, by inhibiting conversion of 
T4 to T3 can cause similar pattern of TFTs. A less well 
recognized cause is heparin administration. Both 
fractionated and unfractionated heparin can produce 
artefactual increase in measured levels of free thyroid 
hormones. Heparin activates endothelial lipoprotein 
lipase which produces an increase in free fatty acids 
that in some individuals, leads to displacement of T4 
and T3 from their carrier protein binding sites thus 
8,9
raising free TH levels.  For this reason, when thyroid 
disease is suspected, samples for TFTs should be 
collected before administration of heparin.
Pregnancy
Pregnancy has a significant impact on HPT physiology 
and may be associated with marked changes in serum 
10
TH and Thyrotropin concentrations.  The levels of 
thyroxine binding globulin (TBG) increase during 
pregnancy due to stimulation of its synthesis in the 
liver by oestrogen. Consequently, the concentration of 
serum total TH increases up to 150% of the values in 
non-pregnant women. Transient increases in serum 
free T4 concentration with a corresponding 
suppression of TSH is often observed in the first 
trimester of pregnancy due to the stimulatory effects of 
human chorionic gonadotropin (hCG) on the TSH 
receptor. Therefore as much as possible, trimester-
specific reference ranges for TH and TSH should be 
used in the evaluation and management of thyroid 
disorders in pregnancy. 
concentrations (e.g. raised T3 and T4 with suppressed 
TSH in thyrotoxicosis; low T3 and T4 with elevated 
TSH in hypothyroidism). However, because the 
population reference ranges for thyroid hormones(TH) 
are relatively wide, changes in TH levels sufficient to 
render a patient hypo-or hyperthyroid may not 
necessarily be associated with numerically abnormal 
T4 or T3 levels ( the so-called subclinical hypo-or 
hyperthyroidism). Consequently, TSH measurement 
has been recommended as the frontline screening test 
for thyroid dysfunction, since relatively modest 
changes in TH concentration are associated with 
1
marked excursions in TSH.  However, when TSH assay 
is used alone, the result can be misleading in the 
following situations: central hypothyroidism (due to 
hypothalamic or pituitary disease) in which the TSH 
can be low, normal or even slightly elevated; recent 
treatment for thyrotoxicosis (TSH remains suppressed 
for up to a year after TH levels have returned to the 
reference range); non-thyroidal illness; TSH-secreting 
pituitary tumour or in individuals with resistance to 
thyroid hormones. For these reasons, most laboratories 
now routinely offer combination screening with both 
T4, T3 and TSH. It is important to note that free TH 
(FT4/FT3) measurements are preferred to total TH 
(TT4/TT3) because of the potential for the latter to be 
affected by changes in circulating binding protein 
levels. 
INTERPRETING TFTs: WHAT TO CONSIDER
In any patient with suspected thyroid disease in whom 
TFTs are requested, the patient's clinical status should 
be reassessed to ascertain whether they are euthyroid, 
hypothyroid or hyperthyroid. This will provide an 
important clue to the test (TSH, T4 and/or T3) that is 
likely to be discordant which will in turn guide further 
management. In addition to the aforementioned, the 
following should be considered while interpreting 
TFTs.
Non-thyroidal illness
Non-thyroidal illness (NTI) formerly called 'sick 
euthyroid syndrome', describes a condition 
characterized by abnormal TFTs encountered in 
patients with acute or chronic systemic disease. NTI 
may affect 60-70% of critically ill patients and occurs in 
3
both organic and psychiatric disease.  Whether it is a 
beneficial response (e.g. to reduce metabolic rate) or a 
maladaptive response (with potential response to TH 
replacement therapy) has been much debated, but 
compelling evidence for the use of T3 or T4 in the 
4
majority of patients with NTI is lacking.  A variety of 
abnormal patterns of TFTs can be seen in NTI. A 
decrease in T3 is the most common finding in these 
3
patients, occurring in even the mildest forms of NTI.  
Levels of FT4 and FT3 are usually low or low normal, 
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searched for in such patients.   Riedel's thyroiditis is a 
rare cause of primary hypothyroidism in which the 
thyroid gland is replaced by fibrosis that often involves 
the surrounding tissues. Autoantibodies are usually 
negative and the condition may be associated with 
15
mediastinal and retroperitoneal fibrosis.  Other causes 
of primary hypothyroidism are shown in Table 2.
The patterns of TFTs discussed so far are consistent 
with the normal negative feedback mechanism of the 
hypothalamic-pituitary thyroid axis whereby when 
THs are high, TSH levels fall and vice versa. These TFTs 
are therefore said to yield convergent results. The 
remaining part of this review will focus on the 
interpretation of divergent TFTs.
Low levels of TSH and normal levels of FT4 and FT3
This pattern of  TFTs suggests subclinical  
hyperthyroidism, a term also referred to as mild 
hyper thyro id ism in  some quar ters .  Most  
Endocrinologists are of the opinion that the term 
'subclinical hyperthyroidism' should be reserved for 
those patients in whom TSH is fully suppressed, 
because this is the group for whom there is the greatest 
evidence of adverse sequelae (in the form of atrial 
fibrillation and osteoporosis) if TSH remains 
s u p p r e s s e d  i n  t h e  l o n g t e r m  ( e s p e c i a l l y  
postmenopausal women and patients older than 65 
16
years of age).  Non-thyroidal illness is another 
common cause of transiently low (albeit not fully 
17
suppressed) TSH, with resolution following recovery.  
In hospitalized patients, treatment with high dose 
glucocorticoids or dopamine can directly suppress 
pituitary release of TSH leading to a similar pattern of 
TFTs. Other causes are shown in Table 3.
Low or normal levels of TSH and low levels of FT4 
and/or FT3
This combination of TFTs is the typical pattern seen in 
patients who are systemically unwell, indicating the 
presence of the so-called non-thyroidal illness (NTI). 
17
The TFTs usually revert to normal with recovery.  In 
the absence of  any obvious NTI,  central  
hypothyroidism must be considered in the differential 
diagnosis of this pattern of TFTs. In such cases, a full 
assessment of anterior pituitary hormones is necessary 
especially to rule out concomitant secondary 
hypoadrenalism. This is because administration of T4 
in a patient with undiagnosed hypocortisolism can 
prove fatal. Imaging studies should also be requested 
to confirm the presence of a pituitary macroadenoma 
which if unrecognized can compress the optic chiasm 
and lead to irreversible visual loss. Other rare causes of 
the above pattern of TFTs are shown in Table 4.
PATTERNS OF THYROID FUNCTION TESTS
Low TSH and raised FT4 and/or FT3
T h i s  p a t t e r n  o f  T F T s  i n d i c a t e s  p r i m a r y  
hyperthyroidism the causes of which include Graves' 
disease, Toxic Multinodular Goitre and Toxic solitary 
adenoma. In all of these cases, the TSH should be 
undetectable (i.e. <0.1mu/L). The causes of this pattern 
of TFTs are shown in Table 1 below. The three most 
common causes of primary hyperthyroidism can 
usually be separated based on clinical criteria. The 
presence of Orbitopathy and a diffuse goitre that is 
nontender makes the diagnosis of Graves' disease 
likely. This is further confirmed by a diffuse uptake on 
radioiodine thyroid scanning and positive antithyroid 
antibodies (especially anti-TSH-Rab (stim) although 
they are negative in about 10% of cases. Transient 
thyroiditis (subacute, silent, or postpartum) should be 
suspected when the history of hyperthyroid symptoms 
is relatively short (<1 month), goitre is tender or 
symptoms occur within 9 months of delivery. 
Thyroiditis can be confirmed by a low uptake on 
radioiodine or technetium thyroid scanning. Elevated 
erythrocyte sedimentation rate (ESR) suggests post-
viral (de Quervain's) thyroiditis. In silent thyroiditis, 
the goitre is usually painless and ESR is normal. 
Ingestion of L-thyroxine, either therapeutic or 
factitious, causes thyroxicosis with low radioiodine 
uptake on thyroid scanning. Amiodarone causes 
thyrotoxicosis in up to 10% of patients treated and can 
11
be difficult to treat.  Hyperemesis gravidarum can be 
associated with mild thyrotoxicosis due to 
overstimulation of TSH receptor by very high human 
chorionic gonadotropin concentrations in the first 
trimester of pregnancy. Familial gestational 
hyperthyroidism is characterized by thyrotoxicosis 
which recurs in subsequent pregnancies and 
spontaneously resolves postpartum. In this rare 
condition, a K183R mutation in the TSH receptor 
increases its ability to be activated by human chorionic 
12
gonadotropin.  Other rarer causes of thyrotoxicosis are 
shown in Table 1. 
Raised TSH and low FT4 and/or FT3
This pattern of TFTs always indicates primary 
hypothyroidism. Iodine deficiency with associated 
endemic goitre (urinary iodine excretion of <45ìg 
daily) is the commonest cause of primary 
hypothyroidism worldwide and should be strongly 
suspected in all patients resident in iodine deficient 
areas. In iodine sufficient areas including the UK, 
primary hypothyroidism is most usually due to either 
autoimmune thyroiditis (Hashimoto's disease or 
atrophic thyroiditis) or follows radioiodine therapy or 
13
thyroidectomy.  Antithyroid peroxidase (anti-TPO) 
antibodies  are found in 95% of patients with 
autoimmune hypothyroidism and these should be 
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considered: a TSH secreting pituitary adenoma 
(TSHoma) and resistance to TH (RTH). Features that 
favour a diagnosis of TSHoma include an increased á-
subunit: TSH molar ratio, the presence of a pituitary 
adenoma on magnetic resonance imaging or computed 
tomography, an attenuated TSH response to 
exogenous TRH administration and an increased level 
of sex-hormone binding globulin (SHBG) (hepatic 
production of SHBG is strongly dependent on thyroid 
19
hormones).  Resistance to thyroid hormone is a genetic  
disorder in which loss-of function mutations in the 
thyroid receptor â (TRâ) isoform are associated with 
variable tissue refractoriness to thyroid hormone 
action, which leads to an altered set-point of the HPT 
axis. A family history of similarly affected individuals 
20
strongly favours the diagnosis of RTH.  Table 6 
summarizes the causes of this pattern of TFTs.
CONCLUSION
Since relatively modest changes in TH concentration 
are associated with marked excursions in TSH, it is 
reasonable to suggest the use of TSH alone as the initial 
screening test for thyroid dysfunction provided the 
limitations of the test are taking into consideration. The 
results of thyroid function tests must always be 
interpreted in the light of the clinical status of the 
patient. When the results appear divergent or 
discordant, confounding factors that may influence 
thyroid status such as intercurrent illness, medications 
or assay interference should be excluded before 
embarking on further biochemical, radiological or 
genetic testing. A sound knowledge of the conditions 
that can be associated with each pattern of TFTs listed 
will go a long way in guiding the choice of additional 
investigations and allowing a correct diagnosis, thus 
avoiding inappropriate treatment.
Increased levels of TSH and normal levels of FT4 
and/or FT3
This pattern of TFTs signifies the so-called 'subclinical 
hypothyroidism'. The condition is reported to affect 5% 
- 10% of women and is commonly associated with 
16 
positive anti-TPO antibodies. Positivity for anti-TPO 
antibodies predict a higher risk of subsequent 
progression to overt hypothyroidism. The TSH level 
should be monitored and if it is persistently elevated 
(>10mU/L), L-thyroxine (LT4) therapy should be 
considered. Other indications for LT4 therapy include: 
younger patients (especially when symptomatic); 
women who wish to become or who are pregnant; and 
16
the presence of marked hypercholesterolaemia.  If the 
level of TSH is increased to a value that is usually 
associated with frankly low level of FT4 or FT3 
(>20mU/L) or the TSH does not show appropriate 
suppression with the introduction or titration of LT4 
therapy, the possibility of interference with TH assays 
should be considered. Other causes of increased levels 
of TSH with normal levels of FT3 and FT4 are shown in 
Table 5.                      
Normal or increased levels of TSH with increased 
levels of FT4 and/or FT3
This pattern of TFTs is most commonly due to assay 
interference e.g. by anti-T4 antibodies or anti-T3 
antibodies or both in the patient's serum, may yield 
artificially increased levels of the hormones; effects of 
drugs such as Amiodarone or heparin or thyroxine 
replacement therapy, including occasional patients 
who ingest large doses of thyroxine just prior to the 
18 
blood test. Non-thyroidal illness especially acute 
psychiatric illness may also be associated with similar 
pattern of TFTs. If all these possibilities have been 
excluded, two rare but important conditions must be 
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Table 1: Conditions in which levels of TSH are low with increased levels of FT4 and/or Ft3
? Graves’ disease  
? Toxic Multinodular goitre  

























?  Pregnancy related  














Metastatic follicular thyroid 
carcinoma
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Table 2: Conditions in which levels of TSH are high with low levels of FT4 and/or Ft3
? Autoimmune thyroiditis  
o  Hashimoto’s thyroiditis  
o  Atrophic thyroiditis  
?
 










Hypothyroid phase of thyroiditis
 ?
 










?  Riedel’s thyroiditis  























Table 3: Conditions in which levels of TSH are low with normal levels of FT4 and Ft3
? Subclinical hyperthyroidism  
? Recent treatment for hyperthyroidism  
?Drugs(glucocorticoids or dopamine)
?  Non-thyroidal illness  
?  Assay interference  
Table 4: Conditions in which levels of TSH are low or normal with low levels of FT4 and Ft3
? Non-thyroidal illness  
? Central hyperthyroidism (for example 
due to anterior pituitary disease)
 
 
?  Isolated TSH deficiency  
 
Table 5: Conditions in which levels of TSH are high with normal levels of FT4 and/or Ft3
? Subclinical hypothyroidism  
o  Autoimmune  
o  Post-thyroid ablation treatment  














Non-thyroidal illness recovery phase
 
 
?  TSH resistance ( for example , 
inactivating germline TSH 
receptor mutation)  
 
Table 6: Conditions in which levels of TSH are high or normal with increased levels of FT4 and/or Ft3
? Interference with assays (for example 
ant-T4 or T3 antibodies)  
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